Navigation Links
Top Biopharma Company Adopts BioFortis' Translational Research Software for Centralized Management and Mining of Clinical Biomarker Data
Date:9/10/2008

COLUMBIA, Md., Sept. 10 /PRNewswire/ -- A top 5 bio-pharmaceutical company has licensed BioFortis' Labmatrix(TM) software for use enterprise-wide, across multiple therapeutic areas within its global Translational Medicine organization, BioFortis officials announced today. This large biopharmaceutical company decided to adopt the Labmatrix technology after an extensive review process that included a pilot by end users and the research informatics division. The company expects full implementation of Labmatrix to have a rapid and profound effect on the productivity of its Translational Medicine efforts.

"Labmatrix is the only data management and exploration application on the market that is built from the ground up to support translational medicine and biomarker discovery," said Jian Wang, BioFortis President and CEO. "There is a growing need in the biotechnology and pharmaceutical industry for robust informatics systems in the translational medicine space. This agreement demonstrates BioFortis' leadership position in fulfilling such needs," Dr. Wang concluded.

Labmatrix, an enterprise translational research information management software product, will be used to support Translational Medicine initiatives associated with research programs, clinical trials, and longitudinal clinical studies conducted with external collaborators.

About BioFortis

BioFortis is a privately-held company focused on providing biomedical research software and services to the life sciences sector, including government and academic research institutes and the biopharmaceutical industry. BioFortis' flagship product Labmatrix(TM) supports translational medicine initiatives with applications in clinical research, biobanking and biomarker discovery. Labmatrix enables transparent data management, integration, collaboration and compliance to privacy regulations.


'/>"/>
SOURCE BioFortis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Therapure Biopharma Inc. opens for business with first client contracts
2. Leading Biopharmas Will Deliver Case Studies on Achieving Productivity Excellence through Engagement, Technology, Other Tools
3. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
4. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
5. Ondine Biopharma Announces Second Quarter 2008 Financial Results
6. Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
7. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
8. Prometic reaches understanding for commercialisation of several biopharmaceutical products and strategic investment
9. ARCA biopharma Appoints James Carr as Vice President of Marketing
10. TriCipher is First to Transfer Smart Card Level Security to Federally Approved SAFE-BioPharma(TM) Roaming Credentials
11. Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 A person commits a crime, and ... to track the criminal down. An outbreak of ... Drug Administration (FDA) uses DNA evidence to track down the ... Sound far-fetched? It,s not. The FDA has increasingly used a ... of foodborne illnesses. Put as simply as possible, whole genome ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... today announced the launch of the Supplyframe Design Lab . Located in ... to explore the future of how hardware projects are designed, built and brought ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
Breaking Biology Technology:
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour ... from the Q1 wave of its quarterly wearables survey. ... receptivity to a program where they would receive discounts ... company. "We were surprised to see that ... LaColla , CEO of Troubadour Research, "primarily because there ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
Breaking Biology News(10 mins):